← back to search

B. Venugopal

Beatson West of Scotland Cancer Centre ·
Area of research
Pulmonary and Respiratory Medicine · Physiology
Research interest
Research interests include Renal cell carcinoma treatment, Economic and Financial Impacts of Cancer, Pancreatic and Hepatic Oncology Research, and Adenosine and Purinergic Signaling.
h-index
18
citations
1,707
works
86
NIH funding
primary concept
Medicine
email

Recent publications

Avelumab + axitinib versus sunitinib as first-line treatment for patients with advanced renal cell carcinoma: final analysis of the phase III JAVELIN Renal 101 trial
Annals of Oncology 2024cited by 45position: middledoi
Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trial
ESMO Open 2021cited by 49position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

B. Yа. Alekseev · Ministry of Health1 papers (2021–2021)Keith A. Ching · Pfizer (United States)1 papers (2021–2021)Brian I. Rini · Cancer Research UK1 papers (2021–2021)Xinmeng Jasmine Mu · Broad Institute1 papers (2021–2021)Sumanta K. Pal · City of Hope1 papers (2021–2021)Bo Huang · University of Hong Kong1 papers (2021–2021)Mehmet Asım Bilen · Emory Healthcare1 papers (2021–2021)Mariangela Mariani · Pfizer (Italy)1 papers (2021–2021)Toni K. Choueiri · Harvard University1 papers (2021–2021)Robert J. Motzer · Texas Oncology1 papers (2021–2021)Paul B. Robbins · Allogene Therapeutics (United States)1 papers (2021–2021)Gwénaëlle Gravis · University College London1 papers (2021–2021)Laurence Albigès · Institut Gustave Roussy1 papers (2021–2021)James Larkin · Trinity College Dublin1 papers (2021–2021)Hideaki Miyake · Hamamatsu University Hospital1 papers (2021–2021)Seetharaman Hariharan · St Thomas' Hospital1 papers (2021–2021)A. Chudnovsky · University of Illinois Chicago1 papers (2021–2021)Alessandra di Pietro · Pfizer (Italy)1 papers (2021–2021)